Stroke prevention in atrial fibrillation among Hong Kong Chinese [2]

Cerebrovascular Diseases

Volumn 11, Issue 4, 2001, Pages 353-354

  Cheung, Raymond T F ^a,c   Li, Leonard S W ^b   Tsang, Kin L ^a   Leung, Kwok P ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUNG WAH HOSPITAL   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; CEREBROVASCULAR ACCIDENT; CHINESE; CONGESTIVE HEART FAILURE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; FEMALE; HONG KONG; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; WARFARIN;

EID: 0034981919     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047668     Document Type: Letter

References (5)

1. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation
3. Drugs and surgery in the prevention of ischemic stroke
4. High prevalence of cagA-positive strains in Helicobacter pylori-infected, healthy, young Chinese adults
5. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial